Anti-FZD1 monoclonal antibody

Anti-FZD1 antibody for FACS & in-vivo assay

Target products collectionGo to FZD1/FZD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0460-Ab-1/ GM-Tg-hg-MP0460-Ab-2Anti-Human FZD1 monoclonal antibodyHuman
GM-Tg-rg-MP0460-Ab-1/ GM-Tg-rg-MP0460-Ab-2Anti-Rat FZD1 monoclonal antibodyRat
GM-Tg-mg-MP0460-Ab-1/ GM-Tg-mg-MP0460-Ab-2Anti-Mouse FZD1 monoclonal antibodyMouse
GM-Tg-cynog-MP0460-Ab-1/ GM-Tg-cynog-MP0460-Ab-2Anti-Cynomolgus/ Rhesus macaque FZD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0460-Ab-1/ GM-Tg-felg-MP0460-Ab-2Anti-Feline FZD1 monoclonal antibodyFeline
GM-Tg-cang-MP0460-Ab-1/ GM-Tg-cang-MP0460-Ab-2Anti-Canine FZD1 monoclonal antibodyCanine
GM-Tg-bovg-MP0460-Ab-1/ GM-Tg-bovg-MP0460-Ab-2Anti-Bovine FZD1 monoclonal antibodyBovine
GM-Tg-equg-MP0460-Ab-1/ GM-Tg-equg-MP0460-Ab-2Anti-Equine FZD1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0460-Ab-1/ GM-Tg-hg-MP0460-Ab-2; GM-Tg-rg-MP0460-Ab-1/ GM-Tg-rg-MP0460-Ab-2;
GM-Tg-mg-MP0460-Ab-1/ GM-Tg-mg-MP0460-Ab-2; GM-Tg-cynog-MP0460-Ab-1/ GM-Tg-cynog-MP0460-Ab-2;
GM-Tg-felg-MP0460-Ab-1/ GM-Tg-felg-MP0460-Ab-2; GM-Tg-cang-MP0460-Ab-1/ GM-Tg-cang-MP0460-Ab-2;
GM-Tg-bovg-MP0460-Ab-1/ GM-Tg-bovg-MP0460-Ab-2; GM-Tg-equg-MP0460-Ab-1/ GM-Tg-equg-MP0460-Ab-2
Products NameAnti-FZD1 monoclonal antibody
Formatmab
Target NameFZD1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FZD1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FZD1 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP0460-Ag-1frizzled class receptor 1 (FZD1) protein
    ORF Viral VectorvGMLP001645human FZD1 Lentivirus particle
    ORF Viral VectorpGMLP001645human FZD1 Lentivirus plasmid
    ORF Viral VectorpGMLPm005207mouse Fzd1 Lentivirus plasmid
    ORF Viral VectorvGMLPm005207mouse Fzd1 Lentivirus particle


    Target information

    Target IDGM-MP0460
    Target NameFZD1
    Gene ID8321,14362,58868,703942,482294,101082735,445417,106783041
    Gene Symbol and Synonymsfrizzled-1,FZ-1,Fz1,FZD1
    Uniprot AccessionQ9UP38,Q08463
    Uniprot Entry NameFZD1_HUMAN,FZD1_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000157240
    Target ClassificationN/A

    The target: FZD1, gene name: FZD1, also named as . Members of the 'frizzled' gene family encode 7-transmembrane domain proteins that are receptors for Wnt signaling proteins.  The FZD1 protein contains a signal peptide, a cysteine-rich domain in the N-terminal extracellular region, 7 transmembrane domains, and a C-terminal PDZ domain-binding motif.  The FZD1 transcript is expressed in various tissues. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.